Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 18 May 2016
At a glance
- Drugs Gefitinib (Primary) ; Vorinostat (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Acronyms VICTORY-J
- 27 Feb 2016 Planned End Date changed from 1 Jun 2016 to 1 Mar 2017.
- 27 Feb 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jan 2017.
- 25 Jul 2014 New trial record